The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' request for confidential information.
The decision was revealed after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative has since clarified that the United States was demanding access to genetic material for research and commercial gain but refused to share the benefits from future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged further negotiations to reach a deal agreeable to both sides so the nation's vital HIV programme can proceed.
Broader Context
This rejection comes after a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government deals to boost openness and responsibility.
Based on reports, 16 nations in Africa have to date signed these new agreements, representing over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"In essence, our country would provide the basic resources for scientific discovery with no certainty that the final treatments would be available to our population if a new disease outbreak emerge."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures already established through the global organization.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with potential pandemics.
"This framework is intended to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be structured in a way that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body stated it understood the official position, but recommended that negotiations must proceed given that a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it commented.
The situation emphasises the continuing challenges between receiving vital international aid and protecting local interests in an increasingly interconnected world.